亚洲男人的天堂2018av,欧美草比,久久久久久免费视频精选,国色天香在线看免费,久久久久亚洲av成人片仓井空

Currently, there is a lot of research in the field of neural networks for non-life insurance pricing. The usual goal is to improve the predictive power via neural networks while building upon the generalized linear model, which is the current industry standard. Our paper contributes to this current journey via novel methods to enhance actuarial non-life models with transformer models for tabular data. We build here upon the foundation laid out by the combined actuarial neural network as well as the localGLMnet and enhance those models via the feature tokenizer transformer. The manuscript demonstrates the performance of the proposed methods on a real-world claim frequency dataset and compares them with several benchmark models such as generalized linear models, feed-forward neural networks, combined actuarial neural networks, LocalGLMnet, and pure feature tokenizer transformer. The paper shows that the new methods can achieve better results than the benchmark models while preserving certain generalized linear model advantages. The paper also discusses the practical implications and challenges of applying transformer models in actuarial settings.

The growing utilization of synthetic medical data (SMD) in training and testing AI-driven tools in healthcare necessitates a systematic framework for assessing SMD quality. The current lack of a standardized methodology to evaluate SMD, particularly in terms of its applicability in various medical scenarios, is a significant hindrance to its broader acceptance and utilization in healthcare applications. Here, we outline an evaluation framework designed to meet the unique requirements of medical applications, and introduce the concept of SMD scorecards, which can serve as comprehensive reports that accompany artificially generated datasets. This can help standardize evaluation and enable SMD developers to assess and further enhance the quality of SMDs by identifying areas in need of attention and ensuring that the synthetic data more accurately approximate patient data.

Medicinal synergy prediction is a powerful tool in drug discovery and development that harnesses the principles of combination therapy to enhance therapeutic outcomes by improving efficacy, reducing toxicity, and preventing drug resistance. While a myriad of computational methods has emerged for predicting synergistic drug combinations, a large portion of them may overlook the intricate, yet critical relationships between various entities in drug interaction networks, such as drugs, cell lines, and diseases. These relationships are complex and multidimensional, requiring sophisticated modeling to capture nuanced interplay that can significantly influence therapeutic efficacy. We introduce a salient deep hypergraph learning method, namely, Heterogeneous Entity Representation for MEdicinal Synergy prediction (HERMES), to predict anti-cancer drug synergy. HERMES integrates heterogeneous data sources, encompassing drug, cell line, and disease information, to provide a comprehensive understanding of the interactions involved. By leveraging advanced hypergraph neural networks with gated residual mechanisms, HERMES can effectively learn complex relationships/interactions within the data. Our results show HERMES demonstrates state-of-the-art performance, particularly in forecasting new drug combinations, significantly surpassing previous methods. This advancement underscores the potential of HERMES to facilitate more effective and precise drug combination predictions, thereby enhancing the development of novel therapeutic strategies.

In the realm of healthcare where decentralized facilities are prevalent, machine learning faces two major challenges concerning the protection of data and models. The data-level challenge concerns the data privacy leakage when centralizing data with sensitive personal information. While the model-level challenge arises from the heterogeneity of local models, which need to be collaboratively trained while ensuring their confidentiality to address intellectual property concerns. To tackle these challenges, we propose a new framework termed Abstention-Aware Federated Voting (AAFV) that can collaboratively and confidentially train heterogeneous local models while simultaneously protecting the data privacy. This is achieved by integrating a novel abstention-aware voting mechanism and a differential privacy mechanism onto local models' predictions. In particular, the proposed abstention-aware voting mechanism exploits a threshold-based abstention method to select high-confidence votes from heterogeneous local models, which not only enhances the learning utility but also protects model confidentiality. Furthermore, we implement AAFV on two practical prediction tasks of diabetes and in-hospital patient mortality. The experiments demonstrate the effectiveness and confidentiality of AAFV in testing accuracy and privacy protection.

Estimating the counterfactual outcome of treatment is essential for decision-making in public health and clinical science, among others. Often, treatments are administered in a sequential, time-varying manner, leading to an exponentially increased number of possible counterfactual outcomes. Furthermore, in modern applications, the outcomes are high-dimensional and conventional average treatment effect estimation fails to capture disparities in individuals. To tackle these challenges, we propose a novel conditional generative framework capable of producing counterfactual samples under time-varying treatment, without the need for explicit density estimation. Our method carefully addresses the distribution mismatch between the observed and counterfactual distributions via a loss function based on inverse probability re-weighting, and supports integration with state-of-the-art conditional generative models such as the guided diffusion and conditional variational autoencoder. We present a thorough evaluation of our method using both synthetic and real-world data. Our results demonstrate that our method is capable of generating high-quality counterfactual samples and outperforms the state-of-the-art baselines.

The development of autonomous agents which can interact with other agents to accomplish a given task is a core area of research in artificial intelligence and machine learning. Towards this goal, the Autonomous Agents Research Group develops novel machine learning algorithms for autonomous systems control, with a specific focus on deep reinforcement learning and multi-agent reinforcement learning. Research problems include scalable learning of coordinated agent policies and inter-agent communication; reasoning about the behaviours, goals, and composition of other agents from limited observations; and sample-efficient learning based on intrinsic motivation, curriculum learning, causal inference, and representation learning. This article provides a broad overview of the ongoing research portfolio of the group and discusses open problems for future directions.

Decision-making algorithms are being used in important decisions, such as who should be enrolled in health care programs and be hired. Even though these systems are currently deployed in high-stakes scenarios, many of them cannot explain their decisions. This limitation has prompted the Explainable Artificial Intelligence (XAI) initiative, which aims to make algorithms explainable to comply with legal requirements, promote trust, and maintain accountability. This paper questions whether and to what extent explainability can help solve the responsibility issues posed by autonomous AI systems. We suggest that XAI systems that provide post-hoc explanations could be seen as blameworthy agents, obscuring the responsibility of developers in the decision-making process. Furthermore, we argue that XAI could result in incorrect attributions of responsibility to vulnerable stakeholders, such as those who are subjected to algorithmic decisions (i.e., patients), due to a misguided perception that they have control over explainable algorithms. This conflict between explainability and accountability can be exacerbated if designers choose to use algorithms and patients as moral and legal scapegoats. We conclude with a set of recommendations for how to approach this tension in the socio-technical process of algorithmic decision-making and a defense of hard regulation to prevent designers from escaping responsibility.

Human doctors with well-structured medical knowledge can diagnose a disease merely via a few conversations with patients about symptoms. In contrast, existing knowledge-grounded dialogue systems often require a large number of dialogue instances to learn as they fail to capture the correlations between different diseases and neglect the diagnostic experience shared among them. To address this issue, we propose a more natural and practical paradigm, i.e., low-resource medical dialogue generation, which can transfer the diagnostic experience from source diseases to target ones with a handful of data for adaptation. It is capitalized on a commonsense knowledge graph to characterize the prior disease-symptom relations. Besides, we develop a Graph-Evolving Meta-Learning (GEML) framework that learns to evolve the commonsense graph for reasoning disease-symptom correlations in a new disease, which effectively alleviates the needs of a large number of dialogues. More importantly, by dynamically evolving disease-symptom graphs, GEML also well addresses the real-world challenges that the disease-symptom correlations of each disease may vary or evolve along with more diagnostic cases. Extensive experiment results on the CMDD dataset and our newly-collected Chunyu dataset testify the superiority of our approach over state-of-the-art approaches. Besides, our GEML can generate an enriched dialogue-sensitive knowledge graph in an online manner, which could benefit other tasks grounded on knowledge graph.

Few-shot Knowledge Graph (KG) completion is a focus of current research, where each task aims at querying unseen facts of a relation given its few-shot reference entity pairs. Recent attempts solve this problem by learning static representations of entities and references, ignoring their dynamic properties, i.e., entities may exhibit diverse roles within task relations, and references may make different contributions to queries. This work proposes an adaptive attentional network for few-shot KG completion by learning adaptive entity and reference representations. Specifically, entities are modeled by an adaptive neighbor encoder to discern their task-oriented roles, while references are modeled by an adaptive query-aware aggregator to differentiate their contributions. Through the attention mechanism, both entities and references can capture their fine-grained semantic meanings, and thus render more expressive representations. This will be more predictive for knowledge acquisition in the few-shot scenario. Evaluation in link prediction on two public datasets shows that our approach achieves new state-of-the-art results with different few-shot sizes.

Applying artificial intelligence techniques in medical imaging is one of the most promising areas in medicine. However, most of the recent success in this area highly relies on large amounts of carefully annotated data, whereas annotating medical images is a costly process. In this paper, we propose a novel method, called FocalMix, which, to the best of our knowledge, is the first to leverage recent advances in semi-supervised learning (SSL) for 3D medical image detection. We conducted extensive experiments on two widely used datasets for lung nodule detection, LUNA16 and NLST. Results show that our proposed SSL methods can achieve a substantial improvement of up to 17.3% over state-of-the-art supervised learning approaches with 400 unlabeled CT scans.